Adamis Pharmaceuticals Corp

Most Recent

Company & Industry Overviews
FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5%
Teva Pharmaceutical Industries (TEVA) received FDA approval for the generic version of Mylan’s (MYL) allergy products EpiPen and EpiPen Jr.

By Sarah CollinsNov. 20 2020, Updated 2:33 p.m. ET
Earnings Report
Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead
During its second-quarter earnings release on August 8, Mylan provided an update on its EpiPen supply shortages.

By Sarah CollinsNov. 20 2020, Updated 5:30 p.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

Adamis Pharmaceuticals Corp

FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5%

Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead